Suppr超能文献

区域卫生系统中肾脏替代治疗综合模型的转变。

Transitions in an integrated model of renal replacement therapy in a regional health system.

作者信息

Gil-Casares Beatriz, Portolés Jose, López-Sánchez Paula, Tornero Fernando, Marques María, Rojo-Álvarez José Luis

机构信息

Servicio de Nefrología, Hospital del Sureste, Arganda del Rey, Madrid, España; Departamento de Teoría de la Señal y Comunicaciones y Sistemas Telemáticos y de Computación, Universidad Rey Juan Carlos, Fuenlabrada, Madrid, España.

Servicio de Nefrología, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, España; REDInREN RETIC ISCIII 16/009/009.

出版信息

Nefrologia (Engl Ed). 2021 Sep 2. doi: 10.1016/j.nefro.2021.07.004.

Abstract

INTRODUCTION AND OBJECTIVES

The choice of renal replacement therapy (RRT) is an important decision that determines the quality of life and survival. Most patients change from one RRT modality to another to adapt RRT to clinical and psychosocial needs. This has been called «integrated model of RRT» that implies new questions about the best sequence of techniques.

MATERIAL AND METHODS

The study describes the impact of transitions between RRT modalities on survival using the Madrid Registry of Renal Patients (2008-2018). This study used the proportional hazards models and competitive risk models to perform an intention-to-treat (ITT), according to their 1 RRT modality and as-treated (AT) analysis, that consider also their 1 transition.

RESULTS

A total of 8971 patients started RRT during this period in Madrid (6.6 Million population): 7207 (80.3%) on hemodialysis (HD), 1401 (15.6%) on peritoneal dialysis (PD) and 363 (4.2%) received a pre-emptive kidney transplantation (KTX). Incident HD-patients were older (HD group 65.3 years (SD 15.3) vs PD group 58.1 years (SD 14.8) vs KTX group 52 years (SD 17.2); p<0.001) and had more comorbidities. They presented higher mortality (HD group 40.9% vs PD group 22.8% vs 8.3% KTX group, p<0.001) and less access to a transplant (HD group 30.4% vs DP group 51.6%; p<0.001). Transitions between dialysis techniques define different groups of patients with different clinical outcomes. Those who change from HD to PD do it earlier (HD→PD: 0.7 years (SD 1.1) vs PD→HD: 1.5 years (SD 1.4) p<0.001), are younger (HD→PD: 53.5 years (SD 16.7) vs PD→HD: 61.6 years (SD 14.6); p<0.001), presented less mortality (HD→PD: 24.5% vs PD→HD: 32.0%; p<0.001) and higher access to a transplant (HD→PD: 49.4% vs PD→HD: 31.7%; p<0.001). Survival analysis by competitive risks is essential for integrated RRT models, especially in groups such as PD patients, where 51.6% of the patients were considered as lost follow-up (received a KTX after during the first 2.5 years on PD). In this analysis, survival of patients who change from one technique to another, is more similar to the destination modality than the origin one.

CONCLUSION

Our data suggest that transitions between RRT-techniques describes different patients, who associate different risks, and could be analyzed in an integrated manner to define improvement actions. This approach should be incorporated into the analysis and reports of renal registries.

摘要

引言与目的

肾脏替代治疗(RRT)方式的选择是决定生活质量和生存情况的重要决策。大多数患者会从一种RRT方式转换为另一种,以使RRT适应临床和心理社会需求。这被称为“RRT综合模式”,这意味着关于最佳技术顺序会产生新的问题。

材料与方法

本研究使用马德里肾脏患者登记处(2008 - 2018年)的数据描述了RRT方式转换对生存的影响。本研究使用比例风险模型和竞争风险模型,根据患者的第一种RRT方式进行意向性治疗(ITT)分析,并进行实际治疗(AT)分析,同时考虑其首次转换情况。

结果

在此期间,马德里共有8971名患者开始接受RRT(人口660万):7207名(80.3%)接受血液透析(HD),1401名(15.6%)接受腹膜透析(PD),363名(4.2%)接受了预先肾脏移植(KTX)。新发HD患者年龄更大(HD组65.3岁(标准差15.3),PD组58.1岁(标准差14.8),KTX组52岁(标准差17.2);p<0.001)且合并症更多。他们的死亡率更高(HD组40.9%,PD组22.8%,KTX组8.3%,p<0.001),接受移植的机会更少(HD组30.4%,DP组51.6%;p<0.001)。透析技术之间的转换定义了具有不同临床结局的不同患者群体。从HD转换为PD的患者更早进行转换(HD→PD:0.7年(标准差1.1),PD→HD:1.5年(标准差1.4),p<0.001),更年轻(HD→PD:53.5岁(标准差16.7),PD→HD:61.6岁(标准差14.6);p<0.001),死亡率更低(HD→PD:24.5%,PD→HD:32.0%;p<0.001),接受移植的机会更高(HD→PD:49.4%,PD→HD:31.7%;p<0.001)。竞争风险生存分析对于RRT综合模式至关重要,尤其是在PD患者等群体中,其中51.6%的患者被视为失访(在PD治疗的前2.5年内接受了KTX)。在该分析中,从一种技术转换为另一种技术的患者的生存情况与目标模式比与起始模式更相似。

结论

我们的数据表明,RRT技术之间的转换描述了不同的患者,这些患者具有不同的风险,可以以综合方式进行分析以确定改进措施。这种方法应纳入肾脏登记处的分析和报告中。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验